These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 23994691)
21. Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogenic estrogen. Jan ST; Devanesan PD; Stack DE; Ramanathan R; Byun J; Gross ML; Rogan EG; Cavalieri EL Chem Res Toxicol; 1998 May; 11(5):412-9. PubMed ID: 9585471 [TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells. Zahid M; Saeed M; Ali MF; Rogan EG; Cavalieri EL Free Radic Biol Med; 2010 Aug; 49(3):392-400. PubMed ID: 20472053 [TBL] [Abstract][Full Text] [Related]
23. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures. Melendez-Colon VJ; Luch A; Seidel A; Baird WM Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961 [TBL] [Abstract][Full Text] [Related]
24. The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and Cavalieri E; Rogan E Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361004 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of depurinating estrogen-DNA adduct formation by natural compounds. Zahid M; Gaikwad NW; Rogan EG; Cavalieri EL Chem Res Toxicol; 2007 Dec; 20(12):1947-53. PubMed ID: 18039013 [TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247 [TBL] [Abstract][Full Text] [Related]
27. Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chen L; Devanesan PD; Higginbotham S; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL Chem Res Toxicol; 1996; 9(5):897-903. PubMed ID: 8828927 [TBL] [Abstract][Full Text] [Related]
28. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757 [TBL] [Abstract][Full Text] [Related]
29. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Cavalieri EL; Kumar S; Todorovic R; Higginbotham S; Badawi AF; Rogan EG Chem Res Toxicol; 2001 Aug; 14(8):1041-50. PubMed ID: 11511178 [TBL] [Abstract][Full Text] [Related]
30. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells. Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038 [TBL] [Abstract][Full Text] [Related]
31. Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease. Zahid M; Saeed M; Yang L; Beseler C; Rogan E; Cavalieri EL IUBMB Life; 2011 Dec; 63(12):1087-93. PubMed ID: 22045657 [TBL] [Abstract][Full Text] [Related]
32. Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones. Stack DE; Li G; Hill A; Hoffman N Chem Res Toxicol; 2008 Jul; 21(7):1415-25. PubMed ID: 18547067 [TBL] [Abstract][Full Text] [Related]
33. Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Cavalieri EL; Rogan EG Future Oncol; 2010 Jan; 6(1):75-91. PubMed ID: 20021210 [TBL] [Abstract][Full Text] [Related]
34. Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene. Saeed M; Higginbotham S; Rogan E; Cavalieri E Chem Biol Interact; 2007 Feb; 165(3):175-88. PubMed ID: 17224140 [TBL] [Abstract][Full Text] [Related]
35. A unified mechanism in the initiation of cancer. Cavalieri EL; Rogan EG Ann N Y Acad Sci; 2002 Apr; 959():341-54. PubMed ID: 11976208 [TBL] [Abstract][Full Text] [Related]
36. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Markushin Y; Zhong W; Cavalieri EL; Rogan EG; Small GJ; Yeung ES; Jankowiak R Chem Res Toxicol; 2003 Sep; 16(9):1107-17. PubMed ID: 12971798 [TBL] [Abstract][Full Text] [Related]
37. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer. Devanesan P; Todorovic R; Zhao J; Gross ML; Rogan EG; Cavalieri EL Carcinogenesis; 2001 Mar; 22(3):489-97. PubMed ID: 11238191 [TBL] [Abstract][Full Text] [Related]
38. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Stack DE; Byun J; Gross ML; Rogan EG; Cavalieri EL Chem Res Toxicol; 1996; 9(5):851-9. PubMed ID: 8828920 [TBL] [Abstract][Full Text] [Related]
39. Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells. Yang L; Zahid M; Liao Y; Rogan EG; Cavalieri EL; Davidson NE; Yager JD; Visvanathan K; Groopman JD; Kensler TW Carcinogenesis; 2013 Nov; 34(11):2587-92. PubMed ID: 23843041 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Saeed M; Rogan E; Cavalieri E Int J Cancer; 2009 Mar; 124(6):1276-84. PubMed ID: 19089919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]